Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

The developers of Tower of Fantasy had a live Q&A in which they detailed the new Warp servers. Announced a few months ago, the Warp servers will gut Tower of Fantasy’s gacha mechanics, and brings back ...

Dima Tower, 24, is on trial for two counts of first-degree murder in the stabbing deaths of his adoptive parents in August 2023. Prosecutors allege Tower stabbed his parents over 140 times, citing ...

A Ukrainian adoptee wept in court as his lawyer detailed his troubled life before he allegedly slaughtered his “caring” American parents. Dima Tower’s audible sobs filled the courtroom in Sarasota, ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

Julio is a Senior Author for Collider. He studied History and International Relations at university, but found his calling in cultural journalism. When he isn't writing, Julio also teaches English at ...

A superstar team of architects and developers insisted on an all-white concrete facade. It could explain some of the building’s problems. A superstar team of architects and developers insisted on an ...